Future Health Esg Stock Net Income
| FHLTDelisted Stock | USD 10.37 0.00 0.00% |
Future Health Esg fundamentals help investors to digest information that contributes to Future Health's financial success or failures. It also enables traders to predict the movement of Future Stock. The fundamental analysis module provides a way to measure Future Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Future Health stock.
Future |
Future Health Esg Company Net Income Analysis
Future Health's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Future Health Net Income | (48.42 K) |
Most of Future Health's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Future Health Esg is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Future Health Esg reported net income of (48,425). This is 100.0% lower than that of the Capital Markets sector and significantly lower than that of the Financials industry. The net income for all United States stocks is 100.01% higher than that of the company.
Future Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Future Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Future Health could also be used in its relative valuation, which is a method of valuing Future Health by comparing valuation metrics of similar companies.Future Health is currently under evaluation in net income category among its peers.
Future Fundamentals
| Return On Asset | -0.0246 | ||||
| Current Valuation | 64.94 M | ||||
| Shares Outstanding | 5.94 M | ||||
| Shares Owned By Insiders | 75.53 % | ||||
| Shares Owned By Institutions | 22.70 % | ||||
| Number Of Shares Shorted | 68 | ||||
| Price To Book | 10.22 X | ||||
| EBITDA | (678.59 K) | ||||
| Net Income | (48.42 K) | ||||
| Cash And Equivalents | 962.01 K | ||||
| Cash Per Share | 0.04 X | ||||
| Current Ratio | 1.45 X | ||||
| Book Value Per Share | (1.73) X | ||||
| Cash Flow From Operations | (717.95 K) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | -0.12 | ||||
| Market Capitalization | 65.06 M | ||||
| Total Asset | 17.23 M | ||||
| Retained Earnings | (10.28 M) | ||||
| Working Capital | (8.31 M) | ||||
| Net Asset | 17.23 M |
About Future Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Future Health Esg's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Future Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Future Health Esg based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Future Stock
If you are still planning to invest in Future Health Esg check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Future Health's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |